Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) EBITDA Margin: 2016-2024

Historic EBITDA Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -0.27%.

  • Organogenesis Holdings' EBITDA Margin rose 832.00% to 13.74% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.80%, marking a year-over-year increase of 101.00%. This contributed to the annual value of -0.27% for FY2024, which is 316.00% down from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' EBITDA Margin is -0.27%, which was down 109.20% from 2.89% recorded in FY2023.
  • Organogenesis Holdings' 5-year EBITDA Margin high stood at 15.45% for FY2021, and its period low was -0.27% during FY2024.
  • For the 3-year period, Organogenesis Holdings' EBITDA Margin averaged around 2.52%, with its median value being 2.89% (2023).
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 1,933bps in 2020, then plummeted by 1,051bps in 2022.
  • Organogenesis Holdings' EBITDA Margin (Yearly) stood at 7.89% in 2020, then skyrocketed by 756bps to 15.45% in 2021, then slumped by 1,051bps to 4.95% in 2022, then crashed by 205bps to 2.89% in 2023, then tumbled by 316bps to -0.27% in 2024.